Rhenman & Partners Asset Management’s MacroGenics MGNX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-287,081	Closed	-$2.53M	–	91
2022 Q1	$2.53M	Sell	287,081 -13,572	-5%	-$150K	0.25%	83
2021 Q4	$4.89M	Sell	300,653 -244,507	-45%	-$4.6M	0.33%	75
2021 Q3	$11.4M	Hold	545,160	–	–	0.8%	49
2021 Q2	$14.6M	Hold	545,160	–	–	0.99%	44
2021 Q1	$17.4M	Sell	545,160 -79,840	-13%	-$1.94M	1.21%	35
2020 Q4	$14.3M	Sell	625,000 -10,711	-2%	-$247K	1.17%	39
2020 Q3	$16M	Sell	635,711 -39,289	-6%	-$1.07M	1.42%	31
2020 Q2	$18.8M	Sell	675,000 -325,000	-33%	-$5.65M	2.04%	12
2020 Q1	$5.82M	Sell	1,000,000 -60,000	-6%	-$545K	0.82%	46
2019 Q4	$11.5M	Buy	1,060,000 +260,627	+33%	+$2.58M	1.26%	34
2019 Q3	$10.2M	Sell	799,373 -57,796	-7%	-$832K	1.28%	33
2019 Q2	$14.5M	Sell	857,169 -110,017	-11%	-$1.89M	1.6%	28
2019 Q1	$17.4M	Buy	967,186 +425,000	+78%	+$7.35M	2.03%	19
2018 Q4	$6.89M	Buy	542,186 +200,600	+59%	+$3.36M	0.79%	49
2018 Q3	$7.32M	Buy	341,586 +16,586	+5%	+$354K	0.73%	54
2018 Q2	$6.71M	Buy	325,000 +25,000	+8%	+$563K	0.69%	55
2018 Q1	$7.55M	Sell	300,000 -8,604	-3%	-$209K	0.93%	46
2017 Q4	$5.86M	Buy	308,604 +86,690	+39%	+$1.62M	0.79%	50
2017 Q3	$4.1M	Buy	221,914 +46,914	+27%	+$813K	0.52%	63
2017 Q2	$3.06M	Hold	175,000	–	–	0.44%	74
2017 Q1	$3.25M	Buy	175,000 +20,000	+13%	+$386K	0.52%	66
2016 Q4	$3.17M	Buy	155,000 +15,000	+11%	+$378K	0.61%	60
2016 Q3	$4.19M	Hold	140,000	–	–	0.67%	53
2016 Q2	$3.78M	Buy	140,000 +20,000	+17%	+$451K	0.67%	57
2016 Q1	$2.25M	Buy	120,000 +26,000	+28%	+$495K	0.45%	72
2015 Q4	$2.91M	Sell	94,000 -13,959	-13%	-$424K	0.44%	68
2015 Q3	$2.31M	Hold	107,959	–	–	0.37%	71
2015 Q2	$4.1M	Buy	107,959 +1,959	+2%	+$64.4K	0.49%	69
2015 Q1	$3.33M	Buy	106,000 +31,000	+41%	+$1.05M	0.56%	59
2014 Q4	$2.63M	Sell	75,000 -10,000	-12%	-$249K	0.76%	53
2014 Q3	$1.78M	Buy	85,000 +25,000	+42%	+$517K	0.52%	82
2014 Q2	$1.3M	Buy	60,000 +40,000	+200%	+$841K	0.39%	80
2014 Q1	$557K	Buy	+20,000	New	+$706K	0.17%	88

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Rhenman & Partners Asset Management's MGNX Position: Q2 2022 in Review

Rhenman & Partners Asset Management sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 287,081 shares — an estimated $2.53M sold.

Rhenman & Partners Asset Management first reported a position in MGNX in Q1 2014 and held it in 33 quarters. The position peaked at $18.8M in Q2 2020. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

Rhenman & Partners Asset Management reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
Rhenman & Partners Asset Management sold 287,081 MacroGenics shares in Q2 2022, an estimated $2.53M.
Rhenman & Partners Asset Management first reported a position in MacroGenics in Q1 2014 and held it in 33 quarters.
Rhenman & Partners Asset Management's MacroGenics position peaked at $18.8M in Q2 2020.
133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.